SJB3-019A
|
S650665-50mg
|
≥99% |
2070015-29-9 |
50mg
|
¥ 6610.9
|
期货,请咨询 |
阿拉丁 |
SJB3-019A
|
S650665-2mg
|
≥99% |
2070015-29-9 |
2mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
SJB3-019A
|
S650665-10mg
|
≥99% |
2070015-29-9 |
10mg
|
¥ 1890.9
|
期货,请咨询 |
阿拉丁 |
SJB3-019A
|
S650665-100mg
|
≥99% |
2070015-29-9 |
100mg
|
¥ 11240.9
|
期货,请咨询 |
阿拉丁 |
Soyasaponin Aa
|
S650657-5mg
|
≥97% |
117230-33-8 |
5mg
|
¥ 9000.9
|
期货,请咨询 |
阿拉丁 |
Saikosaponin B1
|
S650650-5mg
|
≥99% |
58558-08-0 |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Saikosaponin B1
|
S650650-10mg
|
≥99% |
58558-08-0 |
10mg
|
¥ 2700.9
|
期货,请咨询 |
阿拉丁 |
SKF 100398
|
S650630-1mg
|
|
77453-01-1 |
1mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
SGC-iMLLT
|
S650627-5mg
|
≥98% |
2255338-25-9 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
SGC-iMLLT
|
S650627-50mg
|
≥98% |
2255338-25-9 |
50mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
SGC-iMLLT
|
S650627-10mg
|
≥98% |
2255338-25-9 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
SGC-iMLLT
|
S650627-100mg
|
≥98% |
2255338-25-9 |
100mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
SHP389
|
S650586-5mg
|
≥98% |
2235394-90-6 |
5mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
SHP389
|
S650586-50mg
|
≥98% |
2235394-90-6 |
50mg
|
¥ 30000.9
|
期货,请咨询 |
阿拉丁 |
SHP389
|
S650586-25mg
|
≥98% |
2235394-90-6 |
25mg
|
¥ 18000.9
|
期货,请咨询 |
阿拉丁 |
SHP389
|
S650586-10mg
|
≥98% |
2235394-90-6 |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
SHP389
|
S650586-100mg
|
≥98% |
2235394-90-6 |
100mg
|
¥ 46000.9
|
期货,请咨询 |
阿拉丁 |
司美替尼硫酸盐,双特异性丝裂原活化蛋白激酶,MEK1/2 抑制剂
|
S650561-50mg
|
≥99% |
943332-08-9 |
50mg
|
¥ 459.9
|
现货 |
阿拉丁 |
司美替尼硫酸盐,双特异性丝裂原活化蛋白激酶,MEK1/2 抑制剂
|
S650561-500mg
|
≥99% |
943332-08-9 |
500mg
|
¥ 2699.9
|
现货 |
阿拉丁 |
司美替尼硫酸盐,双特异性丝裂原活化蛋白激酶,MEK1/2 抑制剂
|
S650561-1g
|
≥99% |
943332-08-9 |
1g
|
¥ 4599.9
|
现货 |
阿拉丁 |
司美替尼硫酸盐,双特异性丝裂原活化蛋白激酶,MEK1/2 抑制剂
|
S650561-100mg
|
≥99% |
943332-08-9 |
100mg
|
¥ 799.9
|
现货 |
阿拉丁 |
Solitomab
|
S650551-5mg
|
|
1005198-65-1 |
5mg
|
¥ 16800.9
|
期货,请咨询 |
阿拉丁 |
Solitomab
|
S650551-1mg
|
|
1005198-65-1 |
1mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Sigma-1 receptor antagonist 2
|
S650539-5mg
|
≥99% |
1639220-15-7 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |